GRANT Guide

Home » Grants » AACR-Lung Cancer Initiative at Johnson & Johnson Stimulating Therapeutic Advances through Research Training (START) Grants (minority researchers USA)

This opportunity is currently closed.

Sign up for Content Alerts to stay informed when this or related funding opportunities are posted.

AACR-Lung Cancer Initiative at Johnson & Johnson Stimulating Therapeutic Advances through Research Training (START) Grants (minority researchers USA)

The AACR-Lung Cancer Initiative at Johnson & Johnson Stimulating Therapeutic Advances through Research Training (START) Grants is funded by the American Association for Cancer Research (AACR) together with Johnson & Johnson to support lung cancer postdoctoral researchers and clinical fellows in the USA who are from underrepresented populations in biomedical research. These groups include but are not limited to: Blacks or African Americans, Hispanics or Latinos, American Indians and Alaska Natives, Native Hawaiians, and other Pacific Islanders. Applicants must be working in the USA and non-citizen applicants must have the legal right to work in the USA for the duration of the grant. Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent). Applicants must be members of the AACR. The Grant is for 3 years and 1 year of which the recipient may work onsite at a Johnson & Johnson Enterprise Innovation facility. The Award provides 225,000 USD. Applications are due on June 1, 2022.

Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.